Rhinovirus Diagnostics Market Report 2026

Rhinovirus Diagnostics Market Overview

• Rhinovirus Diagnostics market size has reached to $1.58 billion in 2025 • Expected to grow to $2.33 billion in 2030 at a compound annual growth rate (CAGR) of 8.2% • Growth Driver: Rising Respiratory Disorder Prevalence Driving The Market Growth Due To Increasing Air Pollution And Environmental Exposure • Market Trend: Advancements In Rapid Syndromic Molecular Testing And Regulatory Approvals Driving Early Respiratory Infection Detection • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Rhinovirus Diagnostics Market?

Rhinovirus diagnostics refer to laboratory and clinical testing methods used to identify and confirm rhinovirus infections, which are the leading cause of the common cold. These diagnostic tests generally involve the examination of respiratory samples through advanced molecular techniques to enable rapid and accurate virus detection. Rhinovirus diagnostics assist healthcare professionals in making timely treatment decisions, controlling infection transmission, and improving overall patient care and disease management. The main offerings of rhinovirus diagnostics include kits and assays, instruments and platforms, and services and software. Kits and assays refer to ready-to-use diagnostic test kits designed for detecting rhinovirus infections in clinical samples. These diagnostics are based on technologies such as molecular diagnostics, antigen detection, and serology. They are used with sample types including nasal swabs, throat swabs, nasopharyngeal aspirates, and others, and they are used by several end users such as hospitals, diagnostic laboratories, clinics, and others.

What Is The Rhinovirus Diagnostics Market Growth Forecast?

The rhinovirus diagnostics market size is expected to see strong growth in the next few years. It will grow to $2.33 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to rising demand for rapid point-of-care diagnostic solutions, integration of ai-based diagnostic interpretation tools, expansion of multiplex respiratory pathogen testing panels, increasing investment in infectious disease surveillance systems, growth in personalized and precision medicine approaches for respiratory infections. Major trends in the forecast period include ai-assisted rapid respiratory pathogen detection and interpretation, expansion of multiplex pcr-based respiratory virus panels, growth of point-of-care rhinovirus diagnostic testing devices, integration of cloud-based infectious disease surveillance platforms, advancements in high-sensitivity molecular diagnostic assays for early detection.

Global Rhinovirus Diagnostics Market Segmentation

1) By Offering: Kits And Assays, Instruments And Platforms, Services And Software 2) By Technology: Molecular Diagnostics, Antigen Detection, Serology 3) By Sample Type: Nasal Swabs, Throat Swabs, Nasopharyngeal Aspirates, Other Sample Types 4) By End User: Hospitals, Diagnostic Laboratories, Clinics, Other End Users Subsegments: 1) By Kits And Assays: Molecular Diagnostic Kits (Polymerase Chain Reaction Based Assays), Rapid Antigen Detection Kits, Multiplex Respiratory Pathogen Panels 2) By Instruments And Platforms: Automated Immunoassay Analyzers, Point Of Care Diagnostic Devices, Next Generation Sequencing Platforms 3) By Services And Software: Laboratory Information Management Systems, Diagnostic Data Interpretation Software, Cloud Based Reporting And Surveillance Platforms

What Are The Drivers Of The Rhinovirus Diagnostics Market?

The rising prevalence of respiratory disorders is expected to propel the growth of the rhinovirus diagnostics market going forward. Respiratory disorders are conditions that affect the lungs and airways, making it difficult for a person to breathe and properly exchange oxygen. Respiratory disorders are increasing mainly due to rising air pollution, which damages the lungs through continuous exposure to harmful pollutants and weakens respiratory health over time. Rhinovirus diagnostics help in respiratory disorders by quickly detecting rhinovirus infections, enabling timely and accurate treatment decisions that prevent complications and reduce the spread of respiratory illnesses. For instance, in December 2023, according to the National Center for Biotechnology Information, a US-based government agency, the number of Chronic Obstructive Pulmonary Disease (COPD) cases is expected to increase by 112 million, reaching a total of 592 million by 2050, accounting for 9.5% of the total eligible population. Therefore, the rising prevalence of respiratory disorders is driving the growth of the rhinovirus diagnostics industry. The rising healthcare expenditure is expected to propel the growth of the rhinovirus diagnostics market going forward. Healthcare expenditure refers to the total financial resources spent by individuals, organizations, or governments on preventing, treating, and managing health conditions. Healthcare expenditure is increasing due to advancements in medical technology, as new diagnostic tools, treatments, and innovative therapies often come at higher costs, leading to greater overall spending on healthcare. Higher healthcare expenditure supports rhinovirus diagnostics by enabling better access to advanced testing technologies, improving diagnostic infrastructure, and increasing patient affordability and testing rates. For instance, in April 2025, according to the Office for National Statistics, a UK-based independent producer of official statistics, in 2024, the UK’s healthcare spending reached around $ 29.88 billion (£317 billion), reflecting a 6.5% nominal increase compared with 2023. Therefore, the rising healthcare expenditure is driving the growth of the rhinovirus diagnostics industry.

Key Players In The Global Rhinovirus Diagnostics Market

Major companies operating in the rhinovirus diagnostics market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Quest Diagnostics Incorporated, Danaher Corporation (Cepheid), Hologic Inc., Bruker Corporation (ELITechGroup SAS), bioMérieux SA, Qiagen N.V., QuidelOrtho Corporation, DiaSorin S.p.A., Seegene Inc., ARUP Laboratories Inc., Sansure Biotech Inc., SRL Inc., R-Biopharm AG, CerTest Biotec S.L., SpeeDx Pty Ltd, GeneFirst Limited, Atila BioSystems Inc.

Global Rhinovirus Diagnostics Market Trends and Insights

Major companies operating in the rhinovirus diagnostics market are focusing on developing innovative solutions, such as a rapid, syndromic molecular diagnostics platform, to enable fast, accurate, and multiplex detection of respiratory pathogens for improved clinical decision-making. A rapid syndromic molecular diagnostics platform is a testing system that simultaneously identifies multiple pathogens from a single sample using molecular methods to deliver fast and accurate diagnosis of infections. For instance, in April 2023, bioMérieux S.A., a France-based biotechnology company, received U.S. Food and Drug Administration (FDA) 510(k) clearance for the BIOFIRE SPOTFIRE Respiratory (R) Panel Mini and announced plans to pursue CLIA-waiver status for the system. The panel is designed to rapidly detect several respiratory pathogens, including human rhinovirus/enterovirus, directly at the point of care. It supports faster diagnosis, streamlined workflow efficiency, and timely treatment decisions in outpatient and emergency care settings.

Regional Outlook

North America was the largest region in the rhinovirus diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Rhinovirus Diagnostics Market?

The rhinovirus diagnostics market consists of revenues earned by entities by providing services such as respiratory pathogen panel testing, rapid antigen testing, and sample collection services. The market value includes the value of related goods sold by the service provider or included within the service offering. The Rhinovirus diagnostics market also includes sales of PCR analyzers, real-time PCR machines, NGS sequencing instruments, and point-of-care testing devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Rhinovirus Diagnostics Market Report 2026?

The rhinovirus diagnostics market research report is one of a series of new reports from The Business Research Company that provides rhinovirus diagnostics market statistics, including rhinovirus diagnostics industry global market size, regional shares, competitors with a rhinovirus diagnostics market share, detailed rhinovirus diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the rhinovirus diagnostics industry. This rhinovirus diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.